Çam, B. E. Et Al. 2024. miR-98 and miR-629 can be used as a potential biomarker on relapsing-remitting multiple sclerosis patients. Gene Reports , vol.37 .

Çam, B. E., Elgün, T., Köprülü, T. K., Çoban, A., & VURAL KORKUT, Ş., (2024). miR-98 and miR-629 can be used as a potential biomarker on relapsing-remitting multiple sclerosis patients. Gene Reports , vol.37.

Çam, Burçin Et Al. "miR-98 and miR-629 can be used as a potential biomarker on relapsing-remitting multiple sclerosis patients," Gene Reports , vol.37, 2024

Çam, Burçin E. Et Al. "miR-98 and miR-629 can be used as a potential biomarker on relapsing-remitting multiple sclerosis patients." Gene Reports , vol.37, 2024

Çam, B. E. Et Al. (2024) . "miR-98 and miR-629 can be used as a potential biomarker on relapsing-remitting multiple sclerosis patients." Gene Reports , vol.37.

@article{article, author={Burçin Erkal Çam Et Al. }, title={miR-98 and miR-629 can be used as a potential biomarker on relapsing-remitting multiple sclerosis patients}, journal={Gene Reports}, year=2024}